Lactofiltrum at the EAACI -2015 International Congress
Employees of the Department of Development within the Research Division participated in the international EAACI Congress-2015, organized by the European Academy of Allergology and Clinical Immunology, which brought together over 7,600 participants.
A poster presentation based on the work "A double-blind, placebo-controlled, randomized comparative study of the efficacy and safety of Lactofiltrum in atopic dermatitis during a moderate or severe exacerbation phase" was presented at the Congress. The presentation was evaluated by a commission headed by Prof. Tilo Biedermann (Germany). The data received a positive assessment regarding the promising use of prebiotics in combination with an enterosorbent for the therapy of atopic dermatitis.
During the Congress, agreements were reached on collaboration for further research of the drug Lactofiltrum with representatives of the scientific and medical community of European allergists and dermatologists.
Preparations of our production:
On prescription:
Azithromycin Ecomed® tablets 500 mg , Amoxicillin Ekobol® tablets 250 mg , Amoxicillin Ekobol® tablets 500 mg , Amoxicillin tablets 250 mg , Amoxicillin tablets 500 mg , Amiodarone tablets 200 mg , Verapamil tablets 80 mg
Over the counter:
Media Contacts
Subscribe to get the latest news and articles
